We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Vienna, Austria

ESTRO 2023

Session

Monday
May 15
11:40 - 12:40
Plenary Hall
Highlights of Proffered Papers - Latest clinical trials
Anna Kirby, United Kingdom;
Matthias Guckenberger, Switzerland
The latest clinical trials will be presented during this plenary session. Join us to learn of the latest results and developments in clinical trials.
Proffered Papers
Interdisciplinary
11:40 - 11:50
Benefit of AI-assisted organ-at-risk contouring in head-and-neck cancer: A global randomized study
Mathis Ersted Rasmussen, Denmark
OC-0828
11:50 - 12:00
A randomized trial of reduced elective neck dose in head & neck cancer: acute toxicity (NCT02442375)
Maurice Cox, The Netherlands
OC-0829
12:00 - 12:10
Accelerated partial breast irradiation: 10-year results of a randomized GEC-ESTRO phase III trial
Vratislav Strnad, Germany
OC-0830
12:10 - 12:20
Standard vs dose reduced chemoradiotherapy in anal cancer: short-term results of the PLATO-ACT4 RCT
Alexandra Gilbert, United Kingdom
OC-0831
12:20 - 12:30
Organ Preservation in Early rectal Adenocarcinoma : 4-year results of the OPERA trial
Jean-Pierre Gerard, France
OC-0832
12:30 - 12:40
Randomised phase II trial of adaptive image guided bladder radiotherapy: Disease control data
Robert Huddart, United Kingdom
OC-0833